IMDX
Financials
- Market Capitalization 155.64 M
- Employee 58
- Founded 2009
- CEO N/A
- Website www.imdxinc.com
- Headquarter California, United States
- FIGI BBG008P5VFV1
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3255 |  LAB Standard BioTools Inc. - Common Stock | 0.84 USD | 0.00% | -5.62% | 0.00% | -31.71% | 327.66 M USD | ||
| 3598 |  BDSX Biodesix, Inc. - Common Stock | 21.00 USD | -0.62% | +3.86% | +36.99% | +67.87% | 212.28 M USD | ||
| 3872 |  STIM Neuronetics, Inc. - Common Stock | 1.84 USD | +3.95% | +21.05% | +52.07% | -49.17% | 128.04 M USD | ||
| 3964 |  XGN Exagen Inc. - Common Stock | 4.30 USD | +5.13% | -1.60% | -6.11% | -38.48% | 103.89 M USD |
Frequently asked questions about Insight Molecular Diagnostics Inc. - Common Stock
What is the Insight Molecular Diagnostics Inc. - Common Stock stock price today?
The current price of Insight Molecular Diagnostics Inc. - Common Stock (IMDX) is 4.82. Over the past 24 hours, the stock has changed by +8.07%. Follow the IMDX chart for real-time price dynamics.
What is the stock ticker of Insight Molecular Diagnostics Inc. - Common Stock?
Insight Molecular Diagnostics Inc. - Common Stock trades under the ticker IMDX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Insight Molecular Diagnostics Inc. - Common Stock stock going up?
IMDX has changed by +0.21% over the last week, -10.41% over the last month, and +69.72% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Insight Molecular Diagnostics Inc. - Common Stock net income for the last quarter?
Insight Molecular Diagnostics Inc. - Common Stock reported net income of -4.29 M for the last quarter. The previous quarter showed -22.95 M, which means net income changed by +81.31%.
How many employees does Insight Molecular Diagnostics Inc. - Common Stock have?
As of the latest available data, Insight Molecular Diagnostics Inc. - Common Stock has 58 employees. Workforce size can provide additional context about the company's scale and operations.
What is Insight Molecular Diagnostics Inc. - Common Stock EBITDA?
Insight Molecular Diagnostics Inc. - Common Stock EBITDA is -3.81 M, and its EBITDA margin is -42.28 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Insight Molecular Diagnostics Inc. - Common Stock stock?
You can buy Insight Molecular Diagnostics Inc. - Common Stock (IMDX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Insight Molecular Diagnostics Inc. - Common Stock stock?
Investing in Insight Molecular Diagnostics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMDX chart and related analysis on metatrader.com as part of your research.